A Review of Current Guidelines for Depression Treatment
The DOI matches its Crossref record.
Abstract
Article Abstract A variety of American and European guidelines are available for clinicians treating major depressive disorder and depressive subtypes. Major Western guidelines published since 2000 make similar recommendations for all stages of treatment for depression, including a reliance on measurement-based care. First-line treatment is usually a serotonin reuptake inhibitor, psychotherapy, or a combination of pharmacotherapy and psychotherapy. Next-step treatment recommendations are switching or augmentation, depending on patient response to the initial treatment. Maintenance therapy continues the approach that led to remission. The American Psychiatric Association will release a new treatment guideline to offer information on developments made since the last guidelines were published in 2000. Despite progress made during the last decade, no major breakthroughs in the treatment of depression have occurred, and genetic testing developments allowing for personalized care remain the goal of research. This CME activity is expired. For more CME activities, visit cme.psychiatrist.com. Find more articles on this and other psychiatry and CNS topics: The Journal of Clinical Psychiatry The Primary Care Companion for CNS Disorders
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In contrast, the dynamic coupling between frontoparietal activation (which increases with task-directed attention) and default mode deactivation is perturbed in MDD 111,117 .”
From Major depressive disorder (2016) · cites this paper as [117]
In the citing paper
“The dominant approach in contemporary medical science views depression through the lens of a biological model, focusing on physiological factors such as neurochemical imbalances, genetic predispositions, and brain-structure anomalies; common interventions include medication (6, 7), positive-thinking activities (8), and social support (6, 8, 9).”
From Anti-stigmatizing: a collaborative autoethnography on recovery from depression (2024) · cites this paper as [8]
Citations
Cites
Still being checked.
Cited by
Otte, C., Gold, S. M., Penninx, B. W., Pariante, C. M., Etkin, A., Fava, M., Mohr, D. C., & Schatzberg, A. F. (2016) · Nature Reviews Disease Primers · doi:10.1038/nrdp.2016.65 · Cited by 2,269
AGNP Consensus Guidelines for Therapeutic Drug Monitoring in Psychiatry: Update 2011
Hiemke, C., Baumann, P., Bergemann, N., Conca, A., Dietmaier, O., Egberts, K., Fric, M., Gerlach, M., Greiner, C., Gründer, G., et al. (2011) · Pharmacopsychiatry · doi:10.1055/s-0031-1286287 · Cited by 868
Baldessarini, R. J. (2013) · doi:10.1007/978-1-4614-3710-9 · Cited by 365
Uher, R., Perlis, R. H., Placentino, A., Dernovšek, M. Z., Henigsberg, N., Mors, O., Maier, W., McGuffin, P., & Farmer, A. (2012) · Depression and Anxiety · doi:10.1002/da.21993 · Cited by 262
An adaptationist perspective on the etiology of depression
Durisko, Z., Mulsant, B. H., & Andrews, P. W. (2015) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.09.032 · Cited by 140
Gualano, M. R., Bert, F., Martorana, M., Voglino, G., Andriolo, V., Thomas, R., Gramaglia, C., Zeppegno, P., & Siliquini, R. (2017) · Clinical Psychology Review · doi:10.1016/j.cpr.2017.09.006 · Cited by 99
Latest updates on the serotonergic system in depression and anxiety
Lin, J., Liu, W., Guan, J., Cui, J., Shi, R., Wang, L., Chen, D., & Liu, Y. (2023) · Frontiers in Synaptic Neuroscience · doi:10.3389/fnsyn.2023.1124112 · Cited by 111
Treating to target in major depressive disorder: response to remission to functional recovery
McIntyre, R. S., Lee, Y., & Mansur, R. B. (2015) · CNS Spectrums · doi:10.1017/s1092852915000826 · Cited by 84
The importance of components of pulmonary rehabilitation, other than exercise training, in COPD
Hill, K., Vogiatzis, I., & Burtin, C. (2013) · European Respiratory Review · doi:10.1183/09059180.00002913 · Cited by 87
Improving Depression Outcome by Patient-Centered Medical Management
Rush, A. J., & Thase, M. E. (2018) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2018.18040398 · Cited by 76
Lang, R., Hogan, B., Zhu, J., McArthur, K., Lee, J., Zandi, P., Nestadt, P., Silverberg, M. J., Parcesepe, A. M., Cook, J. A., et al. (2023) · AIDS · doi:10.1097/qad.0000000000003420 · Cited by 75
Sundbom, L. T., Bingefors, K., Hedborg, K., & Isacson, D. G. L. (2017) · BJPsych Bulletin · doi:10.1192/pb.bp.116.054270 · Cited by 93
Feng, K., Shen, C., Ma, X., Chen, G., Zhang, M.-L., Xu, B., Liu, X., Sun, J., Zhang, X., Liu, P., et al. (2019) · Psychiatry Research · doi:10.1016/j.psychres.2019.03.015 · Cited by 76
Wu, J., Li, J., Chhetri, G., Muhammad, U., Chen, Y., Li, X., Chen, J., & Wang, Z. (2021) · General Psychiatry · doi:10.1136/gpsych-2021-100529 · Cited by 77
Goldstein, R. B., Chou, S. P., Saha, T. D., Smith, S. M., Jung, J., Zhang, H., Pickering, R. P., Ruan, W. J., Huang, B., & Grant, B. F. (2017) · The Journal of Clinical Psychiatry · doi:10.4088/jcp.15m10358 · Cited by 67
Oved, K., Morag, A., Pasmanik-Chor, M., Rehavi, M., Shomron, N., & Gurwitz, D. (2013) · Translational Psychiatry · doi:10.1038/tp.2013.86 · Cited by 66
Oved, K., Morag, A., Pasmanik-Chor, M., Oron-Karni, V., Shomron, N., Rehavi, M., Stingl, J. C., & Gurwitz, D. (2012) · Pharmacogenomics · doi:10.2217/pgs.12.93 · Cited by 66
Morag, A., Pasmanik-Chor, M., Oron-Karni, V., Rehavi, M., Stingl, J. C., & Gurwitz, D. (2011) · Pharmacogenomics · doi:10.2217/pgs.10.185 · Cited by 59
Kern, D. M., Cepeda, M. S., DeFalco, F., & Etropolski, M. S. (2020) · BMC Psychiatry · doi:10.1186/s12888-019-2418-7 · Cited by 60
Association of Variations in TPH1 and HTR2B with Gestational Weight Gain and Measures of Obesity
Kwak, S. H., Park, B. L., Kim, H., German, M. S., Go, M. J., Jung, H. S., Koo, B. K., Cho, Y. M., Choi, S. H., Cho, Y. S., et al. (2012) · Obesity · doi:10.1038/oby.2011.253 · Cited by 50
Karasz, A., Dowrick, C., Byng, R., Buszewicz, M., Ferri, L., Hartman, T. C. O., van Dulmen, S., van Weel-Baumgarten, E., & Reeve, J. (2012) · British Journal of General Practice · doi:10.3399/bjgp12x616373 · Cited by 49
The Importance of Diet and Gut Health to the Treatment and Prevention of Mental Disorders
Dawson, S. L., Dash, S. R., & Jacka, F. N. (2016) · International Review of Neurobiology · doi:10.1016/bs.irn.2016.08.009 · Cited by 45
Ruiz, M., Moreno, M., Serrano, B. G., Díaz-Oliván, I., Muñoz, L. J., González‐Garrido, C., & Porras‐Segovia, A. (2022) · Current Psychiatry Reports · doi:10.1007/s11920-022-01314-7 · Cited by 55
Wilson, S., Croarkin, P. E., Aaronson, S. T., Carpenter, L. L., Cochran, M., Stultz, D. J., & Kozel, F. A. (2022) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.09.040 · Cited by 40
Toward a very brief quality of life enjoyment and Satisfaction Questionnaire
Rush, A. J., South, C. C., Jha, M. K., Grannemann, B. D., & Trivedi, M. H. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.08.052 · Cited by 39
Blanco, C., Rubio, J. M., Wall, M., Secades-Villa, R., Beesdo-Baum, K., & Wang, S. (2014) · Depression and Anxiety · doi:10.1002/da.22139 · Cited by 36
Kuhn, M., Weidenauer, A., & Pezawas, L. (2014) · Restorative Neurology and Neuroscience · doi:10.3233/rnn-139005 · Cited by 45
Kao, W.-T., Chang, C., & Lung, F. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.06.035 · Cited by 38
Walter, K. H., Otis, N. P., Ray, T. N., Glassman, L. H., Beltran, J. L., Kobayashi Elliott, K. T., & Michalewicz-Kragh, B. (2023) · BMC Psychiatry · doi:10.1186/s12888-022-04452-7 · Cited by 33
Glutamate system as target for development of novel antidepressants
Catena-Dell’Osso, M., Fagiolini, A. M., Rotella, F., Baroni, S., & Marazziti, D. (2013) · CNS Spectrums · doi:10.1017/s1092852912000971 · Cited by 33
Long, N. E. D., Hyslop, J. R., Raha, S., Hardy, D. B., & Holloway, A. C. (2014) · Journal of Affective Disorders · doi:10.1016/j.jad.2014.04.063 · Cited by 34
Guo, F., Zhang, Q., Zhang, B., Fu, Z., Wu, B., Huang, C., & Li, Y. (2014) · European Journal of Neuroscience · doi:10.1111/ejn.12725 · Cited by 29
Jayasooriya, N., Blackwell, J., Saxena, S., Bottle, A., Petersen, I., Creese, H., Hotopf, M., Pollok, R. C. G., & POP‐IBD study group (2022) · Alimentary Pharmacology & Therapeutics · doi:10.1111/apt.16820 · Cited by 27
“10-14 We found two thirds of antidepressant treatment courses prescribed fell short of this duration, leaving individuals inadequately treated.”
Basic psychological need satisfaction and frustration in major depressive disorder
Pietrek, A., Kangas, M., Kliegl, R. M., Rapp, M. A., Heinzel, S., van der Kaap‐Deeder, J., & Heißel, A. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.962501 · Cited by 35
ERICH3: vesicular association and antidepressant treatment response
Liu, D., Zhuang, Y., Zhang, L., Gao, H., Neavin, D. R., Carrillo‐Roa, T., Wang, Y., Yu, J., Qin, S., Kim, D. C., et al. (2020) · Molecular Psychiatry · doi:10.1038/s41380-020-00940-y · Cited by 28
Recommendations for Screening for Depression in Adults
Thase, M. E. (2016) · JAMA · doi:10.1001/jama.2015.18406 · Cited by 29
Bupropion and Escitalopram During Lactation
Neuman, G., Colantonio, D., Delaney, S., Szynkaruk, M., & Ito, S. (2014) · Annals of Pharmacotherapy · doi:10.1177/1060028014529548 · Cited by 25
Zhang, Q., Guo, F., Fu, Z., Zhang, B., Huang, C., & Yang, L. (2015) · Acta Pharmacologica Sinica · doi:10.1038/aps.2015.111 · Cited by 27
The neuroprotective and antidepressant‐like effects of Hcyb1, a novel selective PDE2 inhibitor
Liu, L., Zheng, J., Huang, X., Xia Shuang, Z. H. U., Ding, S., Ke, H., O’Donnell, J. M., Zhang, H., Song, G., & Xu, Y. (2018) · CNS Neuroscience & Therapeutics · doi:10.1111/cns.12863 · Cited by 28
Neuropsychiatric Properties of the ACE2/Ang-(1-7)/Mas Pathway: A Brief Review
de Melo, L. A., & Almeida-Santos, A. F. (2019) · Protein and Peptide Letters · doi:10.2174/0929866527666191223143230 · Cited by 24
Rush, A. J., Conway, C. R., Aaronson, S. T., George, M. S., Riva‐Posse, P., Dünner, D. L., Zajecka, J., Bunker, M. T., Quevedo, J., Allen, R. M., et al. (2024) · Brain stimulation · doi:10.1016/j.brs.2024.12.1187 · Cited by 26
Nothdurfter, C., Schmotz, C., Sarubin, N., Baghai, T. C., Laenger, A., Lieb, M., Bondy, B., Rupprecht, R., & Schüle, C. (2014) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2014.01.013 · Cited by 24
Yang, C., Ning, L., Zhou, F. H., Sun, Q., Meng, H. P., Han, Z., Liu, Y., Huang, W., Liu, S., Li, X. H., et al. (2020) · Neurotoxicity Research · doi:10.1007/s12640-020-00234-9 · Cited by 24
Efficacy of antidepressants: bias in randomized clinical trials and related issues
Wang, S.-M., Han, C., Lee, S.-J., Jun, T.-Y., Patkar, A. A., Masand, P. S., & Pae, C.-U. (2018) · Expert Review of Clinical Pharmacology · doi:10.1080/17512433.2017.1377070 · Cited by 20
Chang, C.-C., Tzeng, N., Yeh, C., Kuo, T. B. J., Huang, S., & Chang, H. (2017) · The World Journal of Biological Psychiatry · doi:10.1080/15622975.2017.1294765 · Cited by 22
Sackeïm, H. A., Aaronson, S. T., Carpenter, L. L., Hutton, T. M., Pages, K. P., Lucas, L., & Chen, B. (2024) · Brain stimulation · doi:10.1016/j.brs.2024.02.019 · Cited by 21
Dudhabhate, B. B., Awathale, S. N., Choudhary, A. G., Subhedar, N. K., & Kokare, D. M. (2024) · Neuroscience · doi:10.1016/j.neuroscience.2024.07.052 · Cited by 19
Li, G., Shen, Y., Luo, J., & Li, H. (2017) · Medicine · doi:10.1097/md.0000000000008142 · Cited by 24
Pharmacogenetics of glutamate system genes and SSRI-associated sexual dysfunction
Bishop, J., Chae, S. S., Patel, S. R., Moline, J., & Ellingrod, V. (2012) · Psychiatry Research · doi:10.1016/j.psychres.2012.03.048 · Cited by 18
Tundo, A., Musetti, L., de Filippis, R., Grande, C. D., Falaschi, V., Proietti, L., & Dell’Osso, L. (2018) · Journal of Affective Disorders · doi:10.1016/j.jad.2018.11.024 · Cited by 17
Najafzadeh, M., Garces, J. A., & Maciel, A. (2017) · PharmacoEconomics · doi:10.1007/s40273-017-0587-0 · Cited by 18
Ebert, B., Miskowiak, K. W., Kloster, M., Johansen, J., Eckholm, C., Wærner, T., Holme, M., & Bruun, L. M. (2017) · BMC Psychiatry · doi:10.1186/s12888-017-1523-8 · Cited by 21
Matsuno, K., Nakamura, K., Aritomi, Y., & Nishimura, A. (2017) · Clinical Pharmacology in Drug Development · doi:10.1002/cpdd.381 · Cited by 16
Antisocial behavioral syndromes and 3‐year quality‐of‐life outcomes in United States adults
Goldstein, R. B., Dawson, D. A., Smith, S. M., & Grant, B. F. (2012) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.2012.01848.x · Cited by 24
Treatment Modalities and Perceived Effectiveness of Treatment Among Adults With Depression
Alang, S., & McAlpine, D. D. (2020) · Health Services Insights · doi:10.1177/1178632920918288 · Cited by 17
Gahr, M., Zeiss, R., Lang, D., Connemann, B. J., Hiemke, C., & Schönfeldt‐Lecuona, C. (2015) · The Journal of Clinical Pharmacology · doi:10.1002/jcph.662 · Cited by 17
Trends of prescription psychotropic medication exposures in pediatric patients, 2009–2018
Hunter, K., Poel, K., Pennington, S., Bindseil, I., Banerji, S., Leonard, J. E., & Wang, G. S. (2021) · Clinical Toxicology · doi:10.1080/15563650.2021.1946556 · Cited by 14
Tada, M., Uchida, H., Suzuki, T., Abe, T., Pollock, B., & Mimura, M. (2014) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000000112 · Cited by 14
Ball, S. G., Classi, P. M., & Dennehy, E. B. (2014) · Annals of General Psychiatry · doi:10.1186/1744-859x-13-8 · Cited by 13
Moreira, L. K. D. S., de Brito, A. F., da Silva, D. M., Siqueira, L., da Silva, D. P. B., Cardoso, C. S., Florentino, I. F., Galdino, P. M., Ghedini, P. C., Menegatti, R., et al. (2020) · Behavioural Brain Research · doi:10.1016/j.bbr.2020.113066 · Cited by 13
Lytsy, P., Hallqvist, J., Alexanderson, K. A. E., & Åhs, A. (2019) · Nordic Journal of Psychiatry · doi:10.1080/08039488.2019.1649723 · Cited by 13
Sackeïm, H. A., Rush, A. J., Greco, T., Jiang, M., Badejo, S., Bunker, M. T., Aaronson, S. T., Conway, C. R., Demyttenaere, K., Young, A. H., et al. (2023) · Psychological Medicine · doi:10.1017/s0033291722003798 · Cited by 12
Predictors of Primary Care Management of Depression in the Veterans Affairs Healthcare System
Chang, E. T., Magnabosco, J. L., Chaney, E. F., Lanto, A. B., Simon, B. F., Yano, E. M., & Rubenstein, L. V. (2014) · Journal of General Internal Medicine · doi:10.1007/s11606-014-2807-z · Cited by 15
New and emerging pharmacologic treatments for MDD
Uyar, A., & Gönül, A. S. (2025) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2025.1621887 · Cited by 20
Pessina, E., Martini, A., Raffone, F., & Martiadis, V. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1299368 · Cited by 12
Matter over mind: How mental health symptom presentations shape diagnostic outcomes
Tate, A. (2019) · Health An Interdisciplinary Journal for the Social Study of Health Illness and Medicine · doi:10.1177/1363459319834991 · Cited by 11
Zhu, M.-J., Shi, J., Chen, Y., Huang, G., Zhu, X., Zhang, S., Huang, X., Song, G., Zhang, H., Ke, H., et al. (2020) · Psychopharmacology · doi:10.1007/s00213-019-05401-1 · Cited by 11
Al‐Harrasi, A., Khan, A., Rehman, N. U., Al‐Shidhani, S., Karim, N., Khan, I., Halim, S. A., Al-Rawahi, A. N., Hussain, J., & Csük, R. (2019) · Phytochemistry · doi:10.1016/j.phytochem.2019.04.007 · Cited by 12
Tredici, A. L. D., Johnson, H. L., DeHart, W. B., Gutin, A., Morin, P. E., Kasten, C. R., Becker, L. K., Taber, K. J., Chawla, D., & Nierenberg, A. A. (2025) · Journal of Clinical Psychopharmacology · doi:10.1097/jcp.0000000000001999 · Cited by 10
Chen, C., Ding, H., Mabry, K. M., & Ko, M. (2022) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2022.173341 · Cited by 10
Aaronson, S. T., Sackeïm, H. A., Jiang, M., Badejo, S., Greco, T., Bunker, M. T., Conway, C. R., Demyttenaere, K., Young, A. H., McAllister-Williams, H., et al. (2023) · Australian & New Zealand Journal of Psychiatry · doi:10.1177/00048674231209837 · Cited by 10
6‐Sulfatoxymelatonin as a predictor of clinical outcome in depressive patients
Hidalgo, M. P. L., Caumo, W., Dantas, G., Franco, D. G., Torres, I. L. D. S., Pezzi, J. C., Elisabetsky, E., Detanico, B. C., Piato, Â., & Markus, R. P. (2011) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.1204 · Cited by 14
Yu, H.-Z., Fu, T., Zhou, J.-N., Ping, K., & Wang, Y. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.629904 · Cited by 10
Hain, D. T., Tredici, A. L. D., Griggs, R. B., Law, R. A., Mabey, B., Johnson, H. L., Taber, K. J., Lynch, K. G., Gutin, A., & Oslin, D. W. (2025) · Frontiers in Pharmacology · doi:10.3389/fphar.2025.1658616 · Cited by 10
Mayes, T. L., Deane, A. E., Aramburu, H., Yagnik, K., & Trivedi, M. H. (2023) · Psychiatric Clinics of North America · doi:10.1016/j.psc.2023.02.002 · Cited by 9
Lv, J.-L., Bai, Y., Lv, Y., Chen, C., Qin, X., Du, G., & Zhou, Y. (2024) · Metabolic Brain Disease · doi:10.1007/s11011-024-01450-4 · Cited by 10
Dhir, A., Malik, S., Kessar, S. V., Singh, K. N., & Kulkarni, S. (2011) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2010.12.003 · Cited by 8
Improving Depression Outcome by Patient-Centered Medical Management
Rush, A. J., & Thase, M. E. (2020) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.18207 · Cited by 9
Giam, A., Chen, L., Hahn, L. A., Gill, S., Clarke, P., Ng, F., Galletly, C. A., & Fitzgerald, P. B. (2021) · Journal of Affective Disorders Reports · doi:10.1016/j.jadr.2021.100162 · Cited by 9
Repurposable Drugs That Interact with Steroid Responsive Gene Targets for Inner Ear Disease
Missner, A. A., Johns, J. D., Gu, S., & Hoa, M. (2022) · Biomolecules · doi:10.3390/biom12111641 · Cited by 8
Israel‐Elgali, I., Pan, H., Oved, K., Pillar, N., Levy, G., Barak, B., Carneiro, A. M. D., Gurwitz, D., & Shomron, N. (2023) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2023.09.012 · Cited by 8
When Screening Is Policy, How Do We Make It Work?
Yawn, B. P., LaRusso, E. M., Bertram, S. L., & Bobo, W. V. (2015) · Wiley eBooks · doi:10.1002/9781118509722.ch2 · Cited by 7
Tundo, A., Musetti, L., Betrò, S., Cambiali, E., de Filippis, R., Marazziti, D., Mucci, F., Proietti, L., & Dell’Osso, L. (2023) · European Psychiatry · doi:10.1192/j.eurpsy.2023.2445 · Cited by 6
Arteaga, A., Tong, X., Zhao, K., Carlisle, N. B., Oathes, D. J., Fonzo, G. A., Keller, C. J., & Zhang, Y. (2025) · Journal of Affective Disorders · doi:10.1016/j.jad.2025.119483 · Cited by 8
Exercise for the Prevention and Treatment of Depression
Alderman, B. L., Perdue, H. M., & Sarwani, A. H. (2024) · Current topics in behavioral neurosciences · doi:10.1007/7854_2024_496 · Cited by 8
Ketamine and Depression: A Review
Ryan, W. C., Marta, C. J., & Koek, R. J. (2014) · International Journal of Transpersonal Studies · doi:10.24972/ijts.2014.33.2.40 · Cited by 6
Tundo, A., Musetti, L., Grande, C. D., de Filippis, R., Proietti, L., Cambiali, E., Franceschini, C., & Dell’Osso, L. (2020) · Human Psychopharmacology Clinical and Experimental · doi:10.1002/hup.2773 · Cited by 6
Raines, A. M., Thomas, E. A., Tock, J. L., Hallinan, T. M., Hartley, S., MacKenna, H., Constans, J. I., & Franklin, C. L. (2020) · Journal of Psychopathology and Behavioral Assessment · doi:10.1007/s10862-019-09778-3 · Cited by 6
Wang, X., Fan, Y., Li, G., & Li, H. (2021) · International Clinical Psychopharmacology · doi:10.1097/yic.0000000000000350 · Cited by 4
“Current antidepressants for MDD have not achieved optimal outcomes (Davidson, 2010; Gelenberg, 2010), and the recurrence rate is still high among patients.”
BackgroundThe first consultation for low mood in general practice: what do patients find helpful?
Morgan, I., Dowrick, C. F., Macdonald, S., Wilkes, S., & Watson, S. (2023) · Family Practice · doi:10.1093/fampra/cmad016 · Cited by 4
Real-Time Driver Depression Monitoring for Accident Prevention in Smart Vehicles
Ahmed, M. H., Saeed, Y., Mehmood, A., Saeed, M., Ahmed, N., Ilyas, Q. M., Iqbal, S., & Abid, N. (2024) · IEEE Access · doi:10.1109/access.2024.3407361 · Cited by 10
Singh, C., Hempel, F., Endres, K., Engelmann, J., & Tarasov, A. (2025) · 2D Materials · doi:10.1088/2053-1583/adce17 · Cited by 4
Depression in Huntington’s Disease
Ossig, C., & Storch, A. (2014) · Neuropsychiatric symptoms of neurological disease · doi:10.1007/978-3-319-09537-0_9 · Cited by 4
Selection Into Mental Health Services Among Persons With Depression
Alang, S., McAlpine, D. D., & McCreedy, E. M. (2020) · Psychiatric Services · doi:10.1176/appi.ps.201900223 · Cited by 4
Carneiro, L., Silva, F., Vasoncelos-Raposo, J., Mota, M. P., Vieira-Coelho, M. A., Deslandes, A., Marinho, H., Amaral, G., & Monteiro-Júnior, R. (2020) · doi:10.21203/rs.3.rs-24600/v1 · Cited by 3
“Regardless of the research growth during the last decade, no major advances have occurred in the treatment of depression [5].”
BackgroundMiller, D. C., Chawla, D., Taber, K. J., Payne, J. L., & Tredici, A. L. D. (2025) · BMC Psychiatry · doi:10.1186/s12888-025-06977-z · Cited by 5
Impact of comorbidities on the cost of depression drug therapy in general practices in Germany
Jacob, L., & Kostev, K. (2016) · Journal of Psychiatric Research · doi:10.1016/j.jpsychires.2016.08.017 · Cited by 4
Koller-Schlaud, K., Ströhle, A., Behr, J., Bärwolf, E., & Rentzsch, J. (2021) · Neuropsychobiology · doi:10.1159/000517860 · Cited by 5
Gross, J., Matko, K., Vennemann, J., & Bringmann, H. C. (2021) · OBM Integrative and Complementary Medicine · doi:10.21926/obm.icm.2104054 · Cited by 4
Raveendran, S., Singh, D., Burke, M. C., McAuliffe‐Fogarty, A. H., Parikh, S. V., McIntyre, R. S., Roy, A., Martin, M., Chrones, L., Opler, M. G. A., et al. (2023) · BMC Psychiatry · doi:10.1186/s12888-023-04922-6 · Cited by 3
Metadata
- Authors
- Gelenberg, A. J.
- Affiliations
- Pennsylvania State University (US)
- Corresponding author
- Gelenberg, Alan J.
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2010-07-15
- Volume
- 71
- Issue
- 07
- Pages
- e15
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2048724816
- Semantic Scholar
- 6cee0e165857b7cd98891dc1aa9fafab5dea6104
- Cited by
- 137
- References
- 0
- Citations by year
- 2026: 3 · 2025: 9 · 2024: 11 · 2023: 12 · 2022: 11 · 2021: 11 · 2020: 14 · 2019: 5 · 2018: 5 · 2017: 10 · 2016: 6 · 2015: 8 · 2014: 14 · 2013: 5 · 2012: 7
- FWCI
- 4.22
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Pharmacology (medical) › Treatment of Major Depression
- Health Sciences › Medicine › Psychiatry and Mental health › Mental Health Treatment and Access
- Social Sciences › Psychology › Experimental and Cognitive Psychology › Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes
- Keywords
- major depressive disorder, measurement-based care, first-line therapy, serotonin reuptake inhibitors, psychotherapy, treatment switching, augmentation therapy, maintenance therapy, personalized medicine, genetic testing
- MeSH terms
- Algorithms, Antidepressive Agents, Combined Modality Therapy, Major Depressive Disorder, Depressive Disorder, Humans, Psychotherapy, Research, Practice Guidelines as Topic, Evidence-Based Medicine
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.